Health

Results: 3985-3996 of 8221

PR Newswire associated0

PeproMene Bio, Inc. and the Institute for Follicular Lymphoma Innovation Announce $11M Investment to Advance PMB-CT01 (BAFF-R CAR T cell therapy) for Relapsed/Refractory Follicular Lymphoma

PR Newswire associated0

GenBio AI Releases Phase 1 of World's First Digital Organism to Transform Medical Research

MindMed to Be Added to the Nasdaq Biotechnology Index

ACRO Announces 2025 Officers and New Members

Vertex Announces Results From Phase 2 Study of Suzetrigine for the Treatment of Painful Lumbosacral Radiculopathy

PR Newswire associated0

Telix Manufacturing Solutions, Brussels South Update: Cyclotron Installation Complete

Implantica strengthens the strategic RefluxStop™ expansion with the addition of yet another key University Hospital in Germany with several more in the pipeline

Dong-A ST Secures European Approval for Stelara Biosimilar IMULDOSA

Sangamo Therapeutics and Astellas Announce Capsid License Agreement to Deliver Genomic Medicines for Neurological Diseases

BioArctic announces global license agreement with Bristol Myers Squibb for BioArctic's PyroGlutamate-amyloid-beta antibody program

GC Aesthetics' PERLE™ Breast Implant features a proprietary surface technology (BioQ™) and GCA’s industry-leading gel technology (Emunomic™ Breast Tissue Dynamic Gel). (Photo: Business Wire)

GC Aesthetics® Announces Decade-Long Clinical Evaluation of PERLE™ Breast Implants

User with GTT@home test device (Photo: Business Wire)

New at-home test from Digostics delivers more accurate gestational diabetes diagnoses as study reveals NHS misses more than 50% of cases